Article info
Recent advances in clinical practice
Targeting the gut-liver-immune axis to treat cirrhosis
- Correspondence to Professor Debbie Lindsay Shawcross, Institute of Liver Studies and Transplantation, King's College London, London WC2R 2LS, UK; debbie.shawcross{at}kcl.ac.uk
Citation
Targeting the gut-liver-immune axis to treat cirrhosis
Publication history
- Received April 14, 2020
- Revised August 12, 2020
- Accepted August 26, 2020
- First published October 15, 2020.
Online issue publication
April 07, 2021
Article Versions
- Previous version (15 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.